We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
- Authors
Hanakawa, Hiroyuki; Orita, Yorihisa; Sato, Yasuharu; Takao, Soshi; Marunaka, Hidenori; Morishita, Tokiwa; Yamashita, Yasuhiko; Hori, Yasutaka; Domae, Shuhei; Inokuchi, Ikuo; Akagi, Seiko; Kondo, Eisei; Iwaki, Noriko; Motomiya, Kana; Okumura, Hirokazu; Yoshino, Tadashi; Nishizaki, Kazunori
- Abstract
Background Few studies have investigated the prognostic factors for nasal natural killer (NK)/T-cell lymphoma. Methods This was a retrospective multicenter clinical study. The clinical records of 36 patients with nasal NK/T-cell lymphoma who had been first treated between 1996 and 2011 were collected from 12 hospitals. Results High serum levels of C-reactive protein (≥1.0 mg/dL), lactate dehydrogenase (≥350 IU/L), and soluble interleukin-2 receptor (sIL-2R; ≥600 U/mL) were associated with worse prognosis. A prognostic score was devised by totaling the number of these 3 predictors: 0 or 1 = score 0; and 2 or 3 = score 1. As for tumor invasion, local invasion beyond the nasal cavity was associated with poor prognosis, and a prognostic score was devised as: tumor restricted to nasal cavity, yes = score 0; no = score 1. A novel prognostic index (NPI) was established based on these scores from 0 to 2. Disease-specific survival rates at 5 years were: 90.0% for NPI = 0; 29.3% for NPI = 1; and 0.0% for NPI = 2. Conclusion Our NPI is valid for anticipating prognosis of nasal NK/T-cell lymphoma. © 2013 Wiley Periodicals, Inc. Head Neck 36: 551-556, 2014
- Subjects
LYMPHOMAS; DRUG receptors; NASAL cavity; BLOOD plasma; DEHYDROGENASES
- Publication
Head & Neck, 2014, Vol 36, Issue 4, p551
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.23322